Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagenic Therapeutics Inc

3.62
+0.13503.87%
Post-market: 3.650.0300+0.83%19:55 EDT
Volume:95.25K
Turnover:343.48K
Market Cap:3.14M
PE:-0.23
High:3.67
Open:3.54
Low:3.52
Close:3.49
Loading ...
Apr 17, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 29, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 02, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 07, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 08, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 05, 2021

Major Issues Report

8-K - Current report
Oct 01, 2021

Major Issues Report

8-K - Current report
Sep 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 19, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]